Kesi Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kesi Xu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Mostafa Jahanifar
University of Warwick
2 shared publications - Adam Shephard
Tissue Image Analytics Centre, Department of Computer Science, University of Warwick, Coventry, UK
1 shared publication - Behnaz Elhaminia
VISION Lab, Department of Computer Science, University of Warwick, Coventry, United Kingdom; Tissue Image Analytics (TIA) Centre, Department of Computer Science, University of Warwick, Coventry, United Kingdom
1 shared publication - Brinder Singh Chohan
Department of Cellular Pathology, University Hospitals of Derby and Burton NHS Foundation Trust, United Kingdom
1 shared publication - Esha Sadia Nasir
VISION Lab, Department of Computer Science, University of Warwick, Coventry, United Kingdom; Tissue Image Analytics (TIA) Centre, Department of Computer Science, University of Warwick, Coventry, United Kingdom
1 shared publication - Fayyaz Minhas
University of Warwick
1 shared publication
Latest Publications
- Open Access
- 25 July 2026
- Published by Elsevier in Medical Image Analysis
- Vol. 114, 104233
KongNet: A multi-headed deep learning model for detection and classification of nuclei in histopathology images
- 25 July 2026
- Published by Elsevier in Medical Image Analysis
- Vol. 114, 104233
Open AccessKongNet: A multi-headed deep learning model for detection and classification of nuclei in histopathology images
- Top Cited PapersOpen Access
- 14 June 2025
- Published by Association for Computing Machinery (ACM) in ACM Computing Surveys
- Vol. 57 (11) , 1-37
Domain Generalization in Computational Pathology: Survey and Guidelines
Deep learning models have exhibited exceptional effectiveness in Computational Pathology (CPath) for various tasks on multi-gigapixel histology images. Nevertheless, the presence of out-of-distribution data (stemming from different sources such as disparate imaging devices) can cause domain shift (DS). DS decreases the generalization of trained models to unseen datasets with slightly different data distributions, prompting the need for innovative domain generalization (DG) solutions. Recognizing the potential of DG to significantly influence diagnostic and prognostic models in cancer studies and clinical practice, we present this survey along with guidelines on achieving DG in CPath. We rigorously define various DS types, systematically review and categorize existing DG approaches and resources in CPath, and provide insights into their advantages, limitations, and applicability. We also conduct thorough benchmarking experiments with 28 cutting-edge DG algorithms to address a complex DG example problem. Our findings suggest that careful experiment design and Stain Augmentation technique can be very effective. However, there is no one-size-fits-all solution for DG in CPath. Therefore, we establish guidelines for detecting and managing DS in different scenarios. While most of the concepts and recommendations are given for applications in CPath, they apply to most medical image analysis tasks as well.
- 14 June 2025
- Published by Association for Computing Machinery (ACM) in ACM Computing Surveys
- Vol. 57 (11) , 1-37
Top Cited PapersOpen AccessDomain Generalization in Computational Pathology: Survey and Guidelines
Deep learning models have exhibited exceptional effectiveness in Computational Pathology (CPath) for various tasks on multi-gigapixel histology images. Nevertheless, the presence of out-of-distribution data (stemming from different sources such as disparate imaging devices) can cause domain shift (DS). DS decreases the generalization of trained models to unseen datasets with slightly different data distributions, prompting the need for innovative domain generalization (DG) solutions. Recognizing the potential of DG to significantly influence diagnostic and prognostic models in cancer studies and clinical practice, we present this survey along with guidelines on achieving DG in CPath. We rigorously define various DS types, systematically review and categorize existing DG approaches and resources in CPath, and provide insights into their advantages, limitations, and applicability. We also conduct thorough benchmarking experiments with 28 cutting-edge DG algorithms to address a complex DG example problem. Our findings suggest that careful experiment design and Stain Augmentation technique can be very effective. However, there is no one-size-fits-all solution for DG in CPath. Therefore, we establish guidelines for detecting and managing DS in different scenarios. While most of the concepts and recommendations are given for applications in CPath, they apply to most medical image analysis tasks as well.